Will Brexit hurt the Ramsay Health Care share price?

The uncertainty surrounding Brexit has already caused a lot of volatility in global markets, however, investors need to consider the potential impacts, on specific companies like Ramsay Health Care Limited Fully Paid Ord. Shrs (ASX: RHC).

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

A deal (or lack thereof) between the United Kingdom and European Union on 29 March is likely to significantly move share markets. The uncertainty surrounding Brexit has already caused a lot of volatility in global markets, however, investors need to consider the potential impacts, on specific companies, over the long term.

Australia's largest private health care company

The Ramsay Health Care Limited Fully Paid Ord. Shrs (ASX: RHC) share price is a 6-bagger over the last decade, with a compound annual growth rate of about 20%. This includes some business stumbles and share price weakness over the last two years, however, the company has achieved this through its scale, diversified portfolio, industry-leading quality, and experienced management. Ramsay boasts that it "delivers a range of acute and primary healthcare services from 480 facilities across 11 countries, making it one of the largest and most diverse private healthcare companies in the world."

By half-year revenue at 31 December 2018, Australasia is Ramsay's largest market with $2.6 billion, followed by continental Europe with roughly $2 billion. Consequently, the United Kingdom is a relatively small percentage of Ramsay's business with less than $400 million in revenue. Group revenue increased 14.9% and EBITDA lifted 9.8% to $5.1 billion and $728.6 million respectively.

Multiple markets

In the UK, despite marginal 1.6% revenue growth, the region posted the only negative EBITDAR contribution of minus 9.2%. Management advised that there was "a good recovery in Q2 NHS volume", after a challenging Q1 which impacted overall earnings. The company is optimistic this improvement will be maintained in the second half. The British population should grow and age over time, even if Brexit makes it harder to work in and migrate to the region.

In Australia, more patients are choosing the public health system with declining private health insurance memberships and high out-of-pocket costs. This is resulting in expectations for low single-digit EPS growth in 2019. Over the longer term, demographic tailwinds and longer life expectancies should support the business.

On 7 November 2018, Ramsay made the strategic acquisition of Europe-based Capio AB. Capio is described by Ramsay as a "quality provider and a leader in driving value-based healthcare, digitalisation and specialisation". The integration plan is underway, with Ramsay expecting the acquisition to be EPS accretive within two to three years.

Foolish takeaway

The economic impacts of Brexit will have a ripple effect throughout the region and may slow corporate growth, and thus spending. As a health care operator, Ramsay should be less impacted than a number of other industries and companies. Demographic tailwinds, international exposure and a relatively low valuation should mean that Ramsay can beat the market over the long term.

Motley Fool contributor Proutlb95 has no position in any of the stocks mentioned and expresses his own opinions. The Motley Fool Australia has recommended Ramsay Health Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A man sits in deep thought with a pen held to his lips as he ponders his computer screen with a laptop open next to him on his desk in a home office environment.
Share Market News

Broker gives its verdict on BHP shares

Let's see what Bell Potter is saying about the Big Australian.

Read more »

A man in his office leans back in his chair with his hands behind his head looking out his window at the city, sitting back and relaxed, confident in his ASX share investments for the long term.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Woman holding gold bar and cheering.
Gold

Why Macquarie expects this surging ASX 200 gold stock could leap another 40%

Macquarie forecasts another year of strong outperformance from this fast-rising ASX 200 gold miner.

Read more »

A young woman looks at here phone as she strides out in an airport dragging her wheelie bag behind her and smiling widely.
Broker Notes

Macquarie tips 15% upside for this ASX 200 industrials stock

Is this transportation business preparing for take-off?

Read more »

Red buy button on an apple keyboard with a finger on it representing asx tech shares to buy today
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

Ten happy friends leaping in the air outdoors.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another momentous session for ASX shares this Friday.

Read more »

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Share Gainers

Why BHP, Catalyst Metals, Mesoblast, and Pilbara Minerals shares are shooting higher

These shares are ending the week with a bang. But why?

Read more »

Disappointed man with his head on his hand looking at a falling share price his a laptop.
Share Fallers

Why 29Metals, Atlas Arteria, DroneShield, and Yancoal shares are falling today

Let's see why these shares are ending the week in the red.

Read more »